Filed 1.1y ago· May 6, 2025
1 day to disclose
Marjorie Taylor Greene
RHouseGeorgia-14
↑bought
Occidental Petroleum
OXY
$1K-$15K
−1.7% vs S&P 500
Trade dateMay 5, 2025
Common Stock
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.




































































































| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
May 6, 2025 1.1y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Occidental Petroleum OXY Common Stock | May 5, 2025 1 day to disclose | Good buy·+$3.4K+42.0% −1.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | American Express AXP Stock | May 5, 2025 1 day to disclose | Good buy·+$891+11.1% +6.3% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Paychex PAYX | May 5, 2025 1 day to disclose | Bad buy·−$2.7K-33.2% −105.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Starbucks SBUX Stock | May 5, 2025 1 day to disclose | Good buy·+$1.5K+18.2% −1.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | FedEx FDX | May 5, 2025 1 day to disclose | Good buy·+$4.1K+51.4% +22.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Occidental Petroleum OXY Common Stock | May 5, 2025 1 day to disclose | Good buy·+$3.4K+42.0% −1.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Blackstone BX | May 5, 2025 1 day to disclose | Bad buy·−$1.6K-19.7% −24.5% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Chevron CVX | May 5, 2025 1 day to disclose | Good buy·+$2.9K+36.6% −7.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | DXC Technology DXC Stock | Apr 29, 2025 7 days to disclose | Flat·+0.0% +77.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Vaxcyte PCVX Vaxcyte, Inc. - | Apr 28, 2025 8 days to disclose | Good buy·+$4.5K+56.4% +20.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Boston Scientific BSX Common Stock | Apr 28, 2025 8 days to disclose | Flat·+0.0% +7.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | ChampionX Corporation CHX ChampionX | Apr 17, 2025 19 days to disclose | price pending | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Crinetics Pharmaceuticals CRNX Common Stock | Apr 17, 2025 19 days to disclose | Good buy·+$3K+37.4% −5.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Vaxcyte PCVX Vaxcyte, Inc. - | Apr 15, 2025 21 days to disclose | Good buy·+$5.6K+70.2% +30.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Vaxcyte PCVX Vaxcyte, Inc. - | Apr 14, 2025 22 days to disclose | Good buy·+$4.8K+60.6% +21.4% vs S&P 500 | $1K-$15K midpoint $8K |
May 2, 2025 1.1y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↑bought | Paychex PAYX ⚑ Technology · Science, Space, and Technology | Apr 9, 2025 23 days to disclose | Bad buy·−$2.5K-31.7% −113.3% vs S&P 500 | $1K-$15K midpoint $8K |
May 2, 2025 1.1y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↑bought | IDEXX Laboratories IDXX Stock ⚑ Healthcare · Research and Technology | Apr 9, 2025 23 days to disclose | Good buy·+$3.3K+41.2% +34.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 2, 2025 1.1y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↑bought | IDEXX Laboratories IDXX Stock ⚑ Healthcare · Research and Technology | Apr 7, 2025 25 days to disclose | Good buy·+$3.8K+48.0% +37.5% vs S&P 500 | $1K-$15K midpoint $8K |
May 2, 2025 1.1y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↑bought | IDEXX Laboratories IDXX Stock ⚑ Healthcare · Research and Technology | Apr 4, 2025 28 days to disclose | Good buy·+$3.4K+42.4% +32.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 2, 2025 1.1y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↑bought | IDEXX Laboratories IDXX Stock ⚑ Healthcare · Research and Technology | Apr 1, 2025 31 days to disclose | Good buy·+$2.7K+34.0% +30.4% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Texas Instruments TXN Common Stock | Apr 8, 2025 20 days to disclose | Flat·+0.0% +106.0% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | FedEx FDX ⚑ Transportation · Transportation and Infrastructure | Apr 8, 2025 20 days to disclose | Flat·+0.0% +49.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Edison International EIX | Apr 8, 2025 20 days to disclose | Flat·+0.0% +51.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Occidental Petroleum OXY Common Stock | Apr 8, 2025 20 days to disclose | Flat·+0.0% +51.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | IDEXX Laboratories IDXX Stock | Apr 8, 2025 20 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Dexcom DXCM | Apr 8, 2025 20 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | CSX Corp CSX CSX ⚑ Transportation · Transportation and Infrastructure | Apr 8, 2025 20 days to disclose | Flat·+0.0% +49.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Becton Dickinson BDX Common Stock | Apr 8, 2025 20 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 23, 2025 1.1y ago | ![]() George Whitesides DHouseCalifornia-27 | ↓sold | Netflix NFLX Netflix, Inc. - | Mar 27, 2025 27 days to disclose | Flat·+0.0% +17.1% vs S&P 500 | $100K-$250K midpoint $175K |
Apr 23, 2025 1.1y ago | ![]() George Whitesides DHouseCalifornia-27 | ↓sold | Texas Instruments TXN Common Stock ⚑ Technology · Science, Space, and Technology | Mar 24, 2025 30 days to disclose | Flat·+0.0% +69.6% vs S&P 500 | $50K-$100K midpoint $75K |
Apr 23, 2025 1.1y ago | ![]() George Whitesides DHouseCalifornia-27 | ↓sold | RTX (Raytheon) RTX RTX Corporation ⚑ Defense · Armed Services | Mar 24, 2025 30 days to disclose | Flat·+0.0% +45.1% vs S&P 500 | $50K-$100K midpoint $75K |
Apr 22, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Texas Instruments TXN Common Stock | Mar 31, 2025 22 days to disclose | Good buy·+$5.8K+72.2% −7.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 22, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Texas Instruments TXN Common Stock | Mar 26, 2025 27 days to disclose | Good buy·+$5.4K+67.7% −5.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | HKXCY Unsponsored ADR | Mar 20, 2025 27 days to disclose | Good buy·+$1.1K+13.8% −18.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | Netflix NFLX Netflix, Inc. - | Mar 3, 2025 44 days to disclose | Bad buy·−$1.2K-14.7% −29.1% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | American Express AXP Stock | Mar 3, 2025 44 days to disclose | Good buy·+$366+4.6% +4.4% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | Starbucks SBUX Stock ⚑ Consumer Cyclical · Highways and Transit | Mar 3, 2025 44 days to disclose | Bad buy·−$1.3K-16.4% −29.1% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | RTX (Raytheon) RTX RTX Corporation | Mar 3, 2025 44 days to disclose | Good buy·+$2.3K+29.0% −20.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | ExxonMobil XOM Stock ⚑ Energy · Natural Resources | Mar 3, 2025 44 days to disclose | Good buy·+$3.2K+39.6% +7.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | Boston Scientific BSX Common Stock | Mar 3, 2025 44 days to disclose | Bad buy·−$4.3K-54.3% −53.5% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | Freeport-McMoRan FCX Stock ⚑ Basic Materials · Natural Resources | Mar 3, 2025 44 days to disclose | Good buy·+$8K+100.5% +82.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | Chevron CVX ⚑ Energy · Natural Resources | Mar 3, 2025 44 days to disclose | Good buy·+$1.7K+20.9% −10.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 15, 2025 1.1y ago | ![]() Rick Larsen DHouseWashington-02 | ↑bought | American Express AXP Stock | Apr 9, 2025 6 days to disclose | Good buy·+$1.4K+17.8% +8.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | ![]() Byron Donalds RHouseFlorida-19 | ↓sold | Vertex Pharmaceuticals VRTX - | Mar 20, 2025 25 days to disclose | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | ![]() Byron Donalds RHouseFlorida-19 | ↓sold | Vertex Pharmaceuticals VRTX - | Mar 20, 2025 25 days to disclose | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | ![]() Byron Donalds RHouseFlorida-19 | ↓sold | Equifax EFX Equifax, Inc. | Mar 20, 2025 25 days to disclose | Flat·+0.0% +32.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 14, 2025 1.1y ago | ![]() Byron Donalds RHouseFlorida-19 | ↓sold | Equifax EFX Equifax, Inc. | Mar 20, 2025 25 days to disclose | Flat·+0.0% +32.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 11, 2025 1.1y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | FedEx FDX | Apr 8, 2025 3 days to disclose | Good buy·+$5.3K+65.9% +16.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↓sold | IDEX IEX ⚑ Industrials · Aviation | Mar 31, 2025 11 days to disclose | Flat·+0.0% +33.0% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↑bought | Block XYZ Block, Inc. Class A Common Stock, | Mar 31, 2025 11 days to disclose | Good buy·+$22.7K+30.2% −3.9% vs S&P 500 | $50K-$100K midpoint $75K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↑bought | Lam Research LRCX Stock | Mar 31, 2025 11 days to disclose | Good buy·+$278.4K+371.2% +291.9% vs S&P 500 | $50K-$100K midpoint $75K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↑bought | Texas Instruments TXN Common Stock | Mar 31, 2025 11 days to disclose | Good buy·+$23.5K+72.2% −7.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | ![]() Susie Lee DHouseNevada-03 | ↓sold | Starbucks SBUX Stock | Mar 14, 2025 28 days to disclose | Flat·+0.0% +21.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↑bought | Vertex Pharmaceuticals VRTX - | Mar 13, 2025 29 days to disclose | Bad buy·−$5.3K-16.2% −19.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↑bought | Exponent EXPO | Mar 13, 2025 29 days to disclose | Bad buy·−$6.9K-21.3% −57.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↑bought | Texas Instruments TXN Common Stock | Mar 13, 2025 29 days to disclose | Good buy·+$25.4K+78.2% | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↑bought | IDEXX Laboratories IDXX Stock | Mar 13, 2025 29 days to disclose | Good buy·+$11.3K+34.8% +31.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | ![]() Carol D. Miller RHouseWest Virginia-01 | ↓sold | Quest Diagnostics DGX Common Stock ⚑ Healthcare · Ways and Means | Mar 10, 2025 32 days to disclose | Flat·+0.0% +0.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↓sold | Lam Research LRCX Stock | Mar 5, 2025 37 days to disclose | Flat·+0.0% +67.1% vs S&P 500 | $50K-$100K midpoint $75K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↑bought | Axon Enterprise AXON | Mar 5, 2025 37 days to disclose | Bad buy·−$7.3K-22.6% −51.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↓sold | Becton Dickinson BDX Common Stock | Mar 5, 2025 37 days to disclose | Flat·+0.0% −0.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↓sold | American Express AXP Stock | Mar 5, 2025 37 days to disclose | Flat·+0.0% +3.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↓sold | Vaxcyte PCVX Vaxcyte, Inc. - | Mar 5, 2025 37 days to disclose | Flat·+0.0% +28.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 10, 2025 1.2y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Crinetics Pharmaceuticals CRNX Common Stock | Mar 19, 2025 22 days to disclose | Flat·+0.0% +32.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 9, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Texas Instruments TXN Common Stock | Mar 10, 2025 30 days to disclose | Good buy·+$5.3K+65.9% −11.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 8, 2025 1.2y ago | ![]() Greg Landsman DHouseOhio-01 | ↓sold | L3Harris Technologies LHX Stock | Mar 27, 2025 12 days to disclose | Flat·+0.0% +46.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 8, 2025 1.2y ago | ![]() Greg Landsman DHouseOhio-01 | ↓sold | Equinix EQIX Equinix, Inc. - | Mar 27, 2025 12 days to disclose | Flat·+0.0% +7.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 8, 2025 1.2y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | TJX Companies TJX | Mar 10, 2025 29 days to disclose | Good buy·+$2.5K+30.7% +10.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 8, 2025 1.2y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | TJX Companies TJX | Mar 10, 2025 29 days to disclose | Good buy·+$2.5K+30.7% +10.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2025 1.2y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | FedEx FDX | Apr 4, 2025 3 days to disclose | Good buy·+$4.5K+56.4% +8.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2025 1.2y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Lam Research LRCX Stock | Apr 4, 2025 3 days to disclose | Good buy·+$38.4K+479.7% +376.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2025 1.2y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | FedEx FDX | Apr 3, 2025 4 days to disclose | Good buy·+$4.2K+52.2% +13.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2025 1.2y ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Hologic HOLX | Mar 31, 2025 7 days to disclose | price pending | $1K-$15K midpoint $8K |
Apr 7, 2025 1.2y ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Boston Scientific BSX Common Stock | Mar 17, 2025 21 days to disclose | Flat·+0.0% +1.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 2, 2025 1.2y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↑bought | IDEXX Laboratories IDXX Stock ⚑ Healthcare · Research and Technology | Mar 14, 2025 19 days to disclose | Good buy·+$2.8K+35.0% +32.5% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | ExxonMobil XOM Stock | Feb 25, 2025 30 days to disclose | Flat·+0.0% +29.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | CSX Corp CSX CSX ⚑ Transportation · Transportation and Infrastructure | Feb 25, 2025 30 days to disclose | Good buy·+$3.3K+41.7% +12.5% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Textron TXT | Feb 25, 2025 30 days to disclose | Flat·+0.0% +26.3% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Occidental Petroleum OXY Common Stock | Feb 25, 2025 30 days to disclose | Good buy·+$4.1K+12.7% −16.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Teleflex TFX | Feb 25, 2025 30 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Dexcom DXCM | Feb 25, 2025 30 days to disclose | Bad buy·−$1.4K-17.6% −17.4% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Extra Space Storage EXR Stock ⚑ Real Estate · Economic Development, Public Buildings, and Emergency Management | Feb 25, 2025 30 days to disclose | Flat·+0.0% +4.3% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Freeport-McMoRan FCX Stock ⚑ Basic Materials · Conservation, Research, and Biotechnology | Feb 25, 2025 30 days to disclose | Flat·+0.0% +15.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | IDEXX Laboratories IDXX Stock | Feb 25, 2025 30 days to disclose | Good buy·+$1.5K+19.1% +19.3% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 20, 2025 1.2y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↓sold | T TPX Common Stock | Feb 28, 2025 20 days to disclose | price pending | $1K-$15K midpoint $8K |
Mar 20, 2025 1.2y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↑bought | Paychex PAYX ⚑ Technology · Science, Space, and Technology | Feb 27, 2025 21 days to disclose | Bad buy·−$2.6K-32.9% −99.3% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 20, 2025 1.2y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↓sold | T TPX Common Stock | Feb 22, 2025 26 days to disclose | price pending | $1K-$15K midpoint $8K |
Mar 20, 2025 1.2y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↓sold | T TPX Common Stock | Feb 21, 2025 27 days to disclose | price pending | $1K-$15K midpoint $8K |
Mar 20, 2025 1.2y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↑bought | Paychex PAYX ⚑ Technology · Science, Space, and Technology | Feb 21, 2025 27 days to disclose | Bad buy·−$2.6K-32.8% −90.4% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 20, 2025 1.2y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↓sold | T TPX Common Stock | Feb 17, 2025 31 days to disclose | price pending | $1K-$15K midpoint $8K |
Mar 20, 2025 1.2y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↓sold | T TPX Common Stock | Feb 16, 2025 32 days to disclose | price pending | $1K-$15K midpoint $8K |
Mar 20, 2025 1.2y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↓sold | T TPX Common Stock | Feb 15, 2025 33 days to disclose | price pending | $1K-$15K midpoint $8K |
Mar 20, 2025 1.2y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↑bought | Paychex PAYX ⚑ Technology · Science, Space, and Technology | Feb 9, 2025 39 days to disclose | Bad buy·−$2.6K-32.1% −88.8% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 20, 2025 1.2y ago | ![]() April McClain Delaney DHouseMaryland-06 | ↑bought | Paychex PAYX ⚑ Technology · Science, Space, and Technology | Feb 5, 2025 43 days to disclose | Bad buy·−$2.7K-33.8% −91.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 19, 2025 1.2y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Blackstone BX | Mar 17, 2025 2 days to disclose | Bad buy·−$2.1K-26.0% −31.6% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 12, 2025 1.2y ago | ![]() Julie Johnson DHouseTexas-32 | ↑bought | RTX (Raytheon) RTX JT RTX Corporation ⚑ Defense · Foreign Affairs | Feb 14, 2025 26 days to disclose | Good buy·+$3.3K+41.1% −8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 12, 2025 1.2y ago | ![]() Julie Johnson DHouseTexas-32 | ↑bought | Freeport-McMoRan FCX Stock | Feb 12, 2025 28 days to disclose | Good buy·+$7K+87.7% +71.7% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 12, 2025 1.2y ago | ![]() Julie Johnson DHouseTexas-32 | ↑bought | Edison International EIX | Feb 12, 2025 28 days to disclose | Good buy·+$2.4K+30.6% +6.2% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 12, 2025 1.2y ago | ![]() Julie Johnson DHouseTexas-32 | ↓sold | MarketAxess Holdings MKTX Common Stock | Feb 12, 2025 28 days to disclose | Flat·+0.0% +1.0% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 12, 2025 1.2y ago | ![]() Julie Johnson DHouseTexas-32 | ↓sold | Amdocs Ltd. DOX Amdocs Limited - Ordinary Shares | Feb 11, 2025 29 days to disclose | Flat·+0.0% +25.7% vs S&P 500 | $1K-$15K midpoint $8K |